{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:31:31Z","timestamp":1782210691331,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"50","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP170005"],"award-info":[{"award-number":["RP170005"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP180672"],"award-info":[{"award-number":["RP180672"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,12,9]]},"DOI":"10.1038\/s41388-022-02538-w","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T12:13:22Z","timestamp":1667909602000},"page":"5373-5384","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["LncRNA PVT-1 promotes osteosarcoma cancer stem-like properties through direct interaction with TRIM28 and TSC2 ubiquitination"],"prefix":"10.1038","volume":"41","author":[{"given":"Susan V.","family":"Tsang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Rainusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonari","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tajhal D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Nakahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Ram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimal","family":"Rajapakshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4183-4939","authenticated-orcid":false,"given":"Cristian","family":"Coarfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz-Kwong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulivarthi H.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2052-0527","authenticated-orcid":false,"given":"Jason T.","family":"Yustein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"2538_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4419-0284-9_1","volume":"152","author":"G Ottaviani","year":"2009","unstructured":"Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res. 2009;152:3\u201313.","journal-title":"Cancer Treat Res"},{"key":"2538_CR2","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1593\/neo.05394","volume":"7","author":"CP Gibbs","year":"2005","unstructured":"Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, et al. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia. 2005;7:967\u201376.","journal-title":"Neoplasia"},{"key":"2538_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","volume":"44","author":"C Peitzsch","year":"2017","unstructured":"Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A. Cancer stem cells: the root of tumor recurrence and metastases. Semin Cancer Biol. 2017;44:10\u201324.","journal-title":"Semin Cancer Biol"},{"key":"2538_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.canlet.2016.11.019","volume":"386","author":"HK Brown","year":"2017","unstructured":"Brown HK, Tellez-Gabriel M, Heymann D. Cancer stem cells in osteosarcoma. Cancer Lett. 2017;386:189\u201395.","journal-title":"Cancer Lett"},{"key":"2538_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-030-14366-4_11","volume":"1139","author":"K Schiavone","year":"2019","unstructured":"Schiavone K, Garnier D, Heymann MF, Heymann D. The heterogeneity of osteosarcoma: the role played by cancer stem cells. Adv Exp Med Biol. 2019;1139:187\u2013200.","journal-title":"Adv Exp Med Biol"},{"key":"2538_CR6","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/bjc.2012.201","volume":"106","author":"JM Houthuijzen","year":"2012","unstructured":"Houthuijzen JM, Daenen LG, Roodhart JM, Voest EE. The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression. Br J Cancer. 2012;106:1901\u20136.","journal-title":"Br J Cancer"},{"key":"2538_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0165-4608(02)00929-9","volume":"144","author":"K Al-Romaih","year":"2003","unstructured":"Al-Romaih K, Bayani J, Vorobyova J, Karaskova J, Park PC, Zielenska M, et al. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities. Cancer Genet Cytogenet. 2003;144:91\u20139.","journal-title":"Cancer Genet Cytogenet"},{"key":"2538_CR8","doi-asserted-by":"publisher","first-page":"e0125611","DOI":"10.1371\/journal.pone.0125611","volume":"10","author":"R Muff","year":"2015","unstructured":"Muff R, Rath P, Ram Kumar RM, Husmann K, Born W, Baudis M, et al. Genomic instability of osteosarcoma cell lines in culture: impact on the prediction of metastasis relevant genes. PLoS ONE. 2015;10:e0125611.","journal-title":"PLoS ONE"},{"key":"2538_CR9","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1093\/carcin\/bgq117","volume":"31","author":"L Mirabello","year":"2010","unstructured":"Mirabello L, Berndt SI, Seratti GF, Burdett L, Yeager M, Chowdhury S, et al. Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis. 2010;31:1400\u20134.","journal-title":"Carcinogenesis."},{"key":"2538_CR10","doi-asserted-by":"publisher","first-page":"304208","DOI":"10.1155\/2015\/304208","volume":"2015","author":"T Colombo","year":"2015","unstructured":"Colombo T, Farina L, Macino G, Paci P. PVT1: a rising star among oncogenic long noncoding RNAs. BioMed Res Int. 2015;2015:304208.","journal-title":"BioMed Res Int"},{"key":"2538_CR11","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/j.1460-2075.1986.tb04578.x","volume":"5","author":"M Graham","year":"1986","unstructured":"Graham M, Adams JM. Chromosome 8 breakpoint far 3\u2019 of the c-myc oncogene in a Burkitt\u2019s lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus. EMBO J. 1986;5:2845\u201351.","journal-title":"EMBO J"},{"key":"2538_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-4939-0856-1_10","volume":"1165","author":"Y Feng","year":"2014","unstructured":"Feng Y, Hu X, Zhang Y, Zhang D, Li C, Zhang L. Methods for the study of long noncoding RNA in cancer cell signaling. Methods Mol Biol. 2014;1165:115\u201343.","journal-title":"Methods Mol Biol"},{"key":"2538_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2015.03.002","volume":"361","author":"D Han","year":"2015","unstructured":"Han D, Wang M, Ma N, Xu Y, Jiang Y, Gao X. Long noncoding RNAs: novel players in colorectal cancer. Cancer Lett. 2015;361:13\u201321.","journal-title":"Cancer Lett"},{"key":"2538_CR14","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm.3981","volume":"21","author":"M Huarte","year":"2015","unstructured":"Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21:1253\u201361.","journal-title":"Nat Med"},{"key":"2538_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1155\/2019\/9325407","volume":"2019","author":"P Du","year":"2019","unstructured":"Du P, Hu C, Qin Y, Zhao J, Patel R, Fu Y, et al. LncRNA PVT1 mediates antiapoptosis and 5-fluorouracil resistance via increasing Bcl2 expression in gastric cancer. J Oncol. 2019;2019:10.","journal-title":"J Oncol"},{"key":"2538_CR16","first-page":"8309","volume":"17","author":"H Fan","year":"2018","unstructured":"Fan H, Zhu JH, Yao XQ. Knockdown of long noncoding RNA PVT1 reverses multidrug resistance in colorectal cancer cells. Mol Med Rep. 2018;17:8309\u201315.","journal-title":"Mol Med Rep"},{"key":"2538_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s13311-018-0649-9","volume":"15","author":"C Fu","year":"2018","unstructured":"Fu C, Li D, Zhang X, Liu N, Chi G, Jin X. LncRNA PVT1 facilitates tumorigenesis and progression of glioma via regulation of MiR-128-3p\/GREM1 axis and BMP signaling pathway. NeuroTherapeutics. 2018;15:1139\u201357.","journal-title":"NeuroTherapeutics"},{"key":"2538_CR18","first-page":"138","volume":"10","author":"G Ping","year":"2018","unstructured":"Ping G, Xiong W, Zhang L, Li Y, Zhang Y, Zhao Y. Silencing long noncoding RNA PVT1 inhibits tumorigenesis and cisplatin resistance of colorectal cancer. Am J Transl Res. 2018;10:138\u201349.","journal-title":"Am J Transl Res"},{"key":"2538_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/jcp.21133","volume":"213","author":"L Carramusa","year":"2007","unstructured":"Carramusa L, Contino F, Ferro A, Minafra L, Perconti G, Giallongo A, et al. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol. 2007;213:511\u20138.","journal-title":"J Cell Physiol"},{"key":"2538_CR20","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/jnci\/djz026","volume":"111","author":"M Nomura","year":"2019","unstructured":"Nomura M, Rainusso N, Lee YC, Dawson B, Coarfa C, Han R, et al. Tegavivint and the \u03b2-Catenin\/ALDH axis in chemotherapy-resistant and metastatic osteosarcoma. J Natl Cancer Inst. 2019;111:1216\u201327.","journal-title":"J Natl Cancer Inst"},{"key":"2538_CR21","doi-asserted-by":"crossref","first-page":"e27579","DOI":"10.1002\/pbc.27579","volume":"66","author":"N Rainusso","year":"2019","unstructured":"Rainusso N, Cleveland H, Hernandez JA, Quintanilla NM, Hicks J, Vasudevan S, et al. Generation of patient-derived tumor xenografts from percutaneous tumor biopsies in children with bone sarcomas. Pediatr Blood Cancer. 2019;66:e27579.","journal-title":"Pediatr Blood Cancer"},{"key":"2538_CR22","doi-asserted-by":"publisher","first-page":"110685","DOI":"10.18632\/oncotarget.22161","volume":"8","author":"S Chen","year":"2017","unstructured":"Chen S, Zhu J, Wang F, Guan Z, Ge Y, Yang X, et al. LncRNAs and their role in cancer stem cells. Oncotarget. 2017;8:110685\u201392.","journal-title":"Oncotarget."},{"key":"2538_CR23","doi-asserted-by":"publisher","first-page":"14016","DOI":"10.1073\/pnas.0906549106","volume":"106","author":"KS Chan","year":"2009","unstructured":"Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci USA. 2009;106:14016\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2538_CR24","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1042\/BST20190778","volume":"48","author":"RR Madsen","year":"2020","unstructured":"Madsen RR. PI3K in stemness regulation: from development to cancer. Biochem Soc Trans. 2020;48:301\u201315.","journal-title":"Biochem Soc Trans"},{"key":"2538_CR25","first-page":"1602","volume":"5","author":"P Xia","year":"2015","unstructured":"Xia P, Xu XY. PI3K\/Akt\/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res. 2015;5:1602\u20139.","journal-title":"Am J Cancer Res"},{"key":"2538_CR26","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/hep.27239","volume":"60","author":"F Wang","year":"2014","unstructured":"Wang F, Yuan JH, Wang SB, Yang F, Yuan SX, Ye C, et al. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2. Hepatology. 2014;60:1278\u201390.","journal-title":"Hepatology"},{"key":"2538_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.18632\/oncotarget.13273","volume":"8","author":"P Czerwi\u0144ska","year":"2017","unstructured":"Czerwi\u0144ska P, Shah PK, Tomczak K, Klimczak M, Mazurek S, Soza\u0144ska B, et al. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development. Oncotarget. 2017;8:863\u201382.","journal-title":"Oncotarget"},{"key":"2538_CR28","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/onc.2016.453","volume":"36","author":"J Li","year":"2017","unstructured":"Li J, Xi Y, Li W, McCarthy RL, Stratton SA, Zou W, et al. TRIM28 interacts with EZH2 and SWI\/SNF to activate genes that promote mammosphere formation. Oncogene. 2017;36:2991\u20133001.","journal-title":"Oncogene."},{"key":"2538_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-12-156","volume":"12","author":"AG Brisbin","year":"2011","unstructured":"Brisbin AG, Asmann YW, Song H, Tsai YY, Aakre JA, Yang P, et al. Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development. BMC Med Genet. 2011;12:156.","journal-title":"BMC Med Genet"},{"key":"2538_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-245","volume":"6","author":"A Letessier","year":"2006","unstructured":"Letessier A, Sircoulomb F, Ginestier C, Cervera N, Monville F, Gelsi-Boyer V, et al. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers. BMC Cancer. 2006;6:245.","journal-title":"BMC Cancer"},{"key":"2538_CR31","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1038\/s41388-018-0310-4","volume":"37","author":"J Tang","year":"2018","unstructured":"Tang J, Li Y, Sang Y, Yu B, Lv D, Zhang W, et al. LncRNA PVT1 regulates triple-negative breast cancer through KLF5\/beta-catenin signaling. Oncogene. 2018;37:4723\u201334.","journal-title":"Oncogene."},{"key":"2538_CR32","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.2147\/CMAR.S263383","volume":"12","author":"H Wang","year":"2020","unstructured":"Wang H, Huang Y, Yang Y. LncRNA PVT1 regulates TRPS1 expression in breast cancer by sponging miR-543. Cancer Manag Res. 2020;12:7993\u20138004.","journal-title":"Cancer Manag Res"},{"key":"2538_CR33","doi-asserted-by":"publisher","first-page":"D601","DOI":"10.1093\/nar\/gky967","volume":"47","author":"B Lang","year":"2019","unstructured":"Lang B, Armaos A, Tartaglia GG. RNAct: protein-RNA interaction predictions for model organisms with supporting experimental data. Nucleic Acids Res. 2019;47:D601\u2013d6.","journal-title":"Nucleic Acids Res"},{"key":"2538_CR34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/bioinformatics\/btv629","volume":"32","author":"CM Livi","year":"2016","unstructured":"Livi CM, Klus P, Delli Ponti R, Tartaglia GG. catRAPID signature: identification of ribonucleoproteins and RNA-binding regions. Bioinformatics. 2016;32:773\u20135.","journal-title":"Bioinformatics"},{"key":"2538_CR35","doi-asserted-by":"publisher","first-page":"52239","DOI":"10.18632\/oncotarget.10469","volume":"7","author":"N Mohan","year":"2016","unstructured":"Mohan N, Shen Y, Dokmanovic M, Endo Y, Hirsch DS, Wu WJ. VPS34 regulates TSC1\/TSC2 heterodimer to mediate RheB and mTORC1\/S6K1 activation and cellular transformation. Oncotarget. 2016;7:52239\u201354.","journal-title":"Oncotarget."},{"key":"2538_CR36","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1073\/pnas.1217692110","volume":"110","author":"Y Yang","year":"2013","unstructured":"Yang Y, Fiskus W, Yong B, Atadja P, Takahashi Y, Pandita TK, et al. Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagy. Proc Natl Acad Sci USA. 2013;110:6841\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2538_CR37","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1021\/acs.jmedchem.0c01491","volume":"64","author":"SP Langston","year":"2021","unstructured":"Langston SP, Grossman S, England D, Afroze R, Bence N, Bowman D, et al. Discovery of TAK-981, a first-in-class inhibitor of SUMO-activating enzyme for the treatment of cancer. J Med Chem. 2021;64:2501\u201320.","journal-title":"J Med Chem"},{"key":"2538_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1051\/sicotj\/2017028","volume":"4","author":"A Misaghi","year":"2018","unstructured":"Misaghi A, Goldin A, Awad M, Kulidjian AA. Osteosarcoma: a comprehensive review. SICOT-J. 2018;4:12.","journal-title":"SICOT-J"},{"key":"2538_CR39","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1093\/nar\/gku278","volume":"42","author":"SA Pradhan","year":"2014","unstructured":"Pradhan SA, Rather MI, Tiwari A, Bhat VK, Kumar A. Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of Epiregulin. Nucleic Acids Res. 2014;42:6243\u201355.","journal-title":"Nucleic Acids Res"},{"key":"2538_CR40","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1038\/sj.onc.1210216","volume":"26","author":"SJ Moschos","year":"2007","unstructured":"Moschos SJ, Smith AP, Mandic M, Athanassiou C, Watson-Hurst K, Jukic DM, et al. SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: identification of Ubc9 as an important molecule in advanced-stage melanomas. Oncogene. 2007;26:4216\u201325.","journal-title":"Oncogene."},{"key":"2538_CR41","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nm.4135","volume":"22","author":"C Adriaens","year":"2016","unstructured":"Adriaens C, Standaert L, Barra J, Latil M, Verfaillie A, Kalev P, et al. p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat Med. 2016;22:861\u20138.","journal-title":"Nat Med"},{"key":"2538_CR42","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1158\/1078-0432.CCR-13-1455","volume":"20","author":"Y Fan","year":"2014","unstructured":"Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, et al. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res. 2014;20:1531\u201341.","journal-title":"Clin Cancer Res"},{"key":"2538_CR43","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1182\/blood-2019-128773","volume":"134","author":"S Assouline","year":"2019","unstructured":"Assouline S, Mehta A, Caimi PF, Wang B, Patel C, Kim M-S, et al. A phase 1b\/2 study of TAK-981, a first-in-class sumoylation inhibitor, in combination with rituximab in patients with relapsed\/refractory (r\/r) CD20-positive non-Hodgkin lymphoma (NHL). Blood. 2019;134:1593.","journal-title":"Blood."},{"key":"2538_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-015-0164-y","volume":"8","author":"X Liu","year":"2015","unstructured":"Liu X, Xu Y, Pang Z, Guo F, Qin Q, Yin T, et al. Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer. J Hematol Oncol. 2015;8:67.","journal-title":"J Hematol Oncol"},{"key":"2538_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07475-5","volume":"9","author":"KW Fong","year":"2018","unstructured":"Fong KW, Zhao JC, Song B, Zheng B, Yu J. TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression. Nat Commun. 2018;9:5007.","journal-title":"Nat Commun"},{"key":"2538_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1158\/0008-5472.CAN-20-0854","volume":"81","author":"A Dasgupta","year":"2021","unstructured":"Dasgupta A, Sierra L, Tsang SV, Kurenbekova L, Patel T, Rajapakse K, et al. Targeting PAK4 inhibits Ras-mediated signaling and multiple oncogenic pathways in high-risk rhabdomyosarcoma. Cancer Res. 2021;81:199\u2013212.","journal-title":"Cancer Res"},{"key":"2538_CR47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2015.03.025","volume":"161","author":"C Chu","year":"2015","unstructured":"Chu C, Zhang QC, da Rocha ST, Flynn RA, Bharadwaj M, Calabrese JM, et al. Systematic discovery of Xist RNA binding proteins. Cell. 2015;161:404\u201316.","journal-title":"Cell."}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02538-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02538-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02538-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T07:30:09Z","timestamp":1701329409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02538-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":47,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2022,12,9]]}},"alternative-id":["2538"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02538-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1813153\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}